Stunning discovery involving the brain-inspiring new questions and treatment for Parkinson’s, Alzheimer’s, dementia, and other neurological disorders: A unifying hypothesis?

References

• Rietdijk CD, Perez-Pardo P, Garssen J, et al. Exploring Braak’s hypothesis of Parkinson’s disease. Front Neurol. 2017 Feb;13(378):1–8.
   Google Scholar
• Jensen TS, Yaksh TL. Effects of intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious response in rats. Brain Res. 1984 Apr 2;296(2):285–293.
   PubMed Web of Science ®Google Scholar
• Shyu BC, Kiritsy-Roy JA, Morrow TJ, et al. Neurophysiological, pharmacological and behavioral evidence for medical thalamic mediation of cocaine induced dopaminergic analgesia. Brain Res. 1992 Feb 14;572(1–2):216–223.
   PubMed Web of Science ®Google Scholar
• Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain. 1995 Jan;60(1):3–38.
   PubMed Web of Science ®Google Scholar
• Altier N, Stewart J. The role of dopamine in the nucleus accumbens in analgesia. J Pharmacol Exp Ther. 1998;285:208–215.
   PubMed Web of Science ®Google Scholar
• Brefel-Courbon C, Patoux P, Thalamas C, et al. Effect of levodopa on pain threshold in Parkinson’s disease: a clinical and positron emission tomography study. Mov Disord. 2005 Dec;20(12):1557–1563.
   PubMed Web of Science ®Google Scholar
• Jääskeläinen SK, Rinne JO, Forssell H, et al. Role of the dopaminergic system in chronic pain – a fluorodopa-PET study. Pain. 2001 Feb 15;90(3):25760.
   Web of Science ®Google Scholar
• Wood PB, Patterson JC 2nd, Sunderland JJ, et al. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain. 2007 Jan;8(1):51–58.
   PubMed Web of Science ®Google Scholar
• Wood PB, Schweinhardt P, Jaeger E, et al. Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci. 2007 Jun;25(12):3576–3582.
   PubMed Web of Science ®Google Scholar
• Cervenka S, Pålhagen SE, Comley RA, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006;129:2017–2028.
   PubMed Web of Science ®Google Scholar
• Nikolaev SV, Lebedev AA, Bychkov ER, et al. The effects of substance P after central administration on the activity of the mesloimbic system of the rat brain as studied by microdialysis. Neurosci Behav Physiol. 2004 Sept;34(7):743–746.
   PubMedGoogle Scholar
• Jennings D. Parkinson’s disease: are some cases misdiagnosed craniomandibular dysfunction? J Am Academy Craniofac Pain. 2008 Apr;21(1):28–33.
   Google Scholar
• de Ceballos ML, Fernandez A, Jenner P, et al. Parallel alterations in Met-enkephalin and substance P levels in medial globus pallidus in Parkinson’s disease patients. Neurosci Lett. 1993 Oct 1;160(2):163–166.
   PubMed Web of Science ®Google Scholar
• Fernandez A, de Ceballos ML, Rose S, et al. Alterations in peptide levels in Parkinson’s disease and incidental Lewy body disease. Brain. 1996 Jun;119(Pt 3):823–830.
   PubMedGoogle Scholar
• Matsuishi T, Nagamitsu S, Shoji H, et al. Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication. J Neural Transm. 1999;106(9–10):943–948.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Fibromyalgia – pathways and neurotransmitters. Hum Psychopharmacol. 2009 Jun;24(Suppl 1):S11–17.
   PubMedGoogle Scholar
• Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994 Nov;37(11):1593–1601.
   PubMed Web of Science ®Google Scholar
• Vaerøy H, Helle R, Førre Ø, et al. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain. 1988;32(1):21–26.
   PubMed Web of Science ®Google Scholar
• Evengard B, Nilsson CG, Lindh G, et al. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain. 1998;78(2):153–155.
   PubMed Web of Science ®Google Scholar
• Russell IJ, Vacrøy H, Javors M, et al. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum. 1992 May;35(5):550–556.
   PubMed Web of Science ®Google Scholar
• Vacrøy H, Nyberg F, Terenius L. No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg6-Phe7. Pain. 1991 Aug;46(2):139–143.
   PubMed Web of Science ®Google Scholar
• Giovengo SL, Russell IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol. 1999 Jul;26(7):1564–1569.
   PubMed Web of Science ®Google Scholar
• Larson AA, Giovengo SL, Russell IJ, et al. Changes in the concentration of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain. 2000 Aug;87(2):201–211.
   PubMed Web of Science ®Google Scholar
• Zhu JP, Xu W, Angulo JA. Distinct mechanisms mediating methamphetamine-induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance P in the striatum of mice. Ann NY Acad Sci. 2006 Aug;1074:135–148.
   PubMed Web of Science ®Google Scholar
• Claassen DO, Josephs KA, Ahlskog JE, et al. REM sleep behavior disorder preceding other apects of synucleinopaties by up to half a century. Neurology. 2010 Jul 29;75:494–499.
   PubMed Web of Science ®Google Scholar
• Claassen DO, Josephs KA, Ahlskog JE, et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology. 2010 Aug 10;75(6):494–499.
   PubMed Web of Science ®Google Scholar
• Louveau A, Smirnov I, Keyes TJ, et al. Altering link between brain, immune system. UVA Today. June 2015.
   Google Scholar
• Louveau A, Kipnis J. The lymphatic drain inside your brain. Startling anatomical discovery could inspire new treatments for Alzheimer’s and other neurological diseases. UVA Today. June 15, 2015.
   Google Scholar